Control Material Kit for Qualitative Detection of SARS-CoV-2 Nucleocapsid Protein Antigen by Chemiluminescent Method "LIAISON Control SARS-CoV-2 Ag", Lots: 372002, 372003, 372004

Control Material Kit for Qualitative Detection of SARS-CoV-2 Nucleocapsid Protein Antigen by Chemiluminescent Method "LIAISON Control SARS-CoV-2 Ag", Lots: 372002, 372003, 372004

Control Material Kit for Qualitative Detection of SARS-CoV-2 Nucleocapsid Protein Antigen Using the Chemiluminescent Method "LIAISON Control SARS-CoV-2 Ag"

We present the control material kit, available in lots 372002, 372003, and 372004, designed for the qualitative detection of the SARS-CoV-2 nucleocapsid protein antigen using the chemiluminescent method.

The kit includes:

• Negative control – 2 vials
• Positive control – 2 vials
• Instructions for use – 1 piece
• Certificate of analysis – 1 piece

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Control Material Kit for Qualitative Detection of SARS-CoV-2 Nucleocapsid Protein Antigen by Chemiluminescent Method "LIAISON Control SARS-CoV-2 Ag", Lots: 372002, 372003, 372004, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.